Human Alpha1 Proteinase Inhibitor Market - Genetic Lung Disease and...

Ajouter une nouvelle offre d'emploi Health

2026-07-20 07:05:34 -

Human Alpha1 Proteinase Inhibitor Market - Genetic Lung Disease and Rare Enzyme Replacement Therapy

Market Overview The global human alpha1 proteinase inhibitor market is experiencing steady growth driven by alpha1-antitrypsin (AAT) deficiency disease recognition, enzyme replacement therapy advancement, and improved access to life-prolonging treatment for this rare genetic lung disease. The human alpha1 proteinase inhibitor market is projected to exceed USD 3.6 billion through 2030, fueled by...

0 Commentaires 0 Parts 662 Vue 0 Aperçu